Results were measured over the course of 3 months.Īt the end of the trial, 65% of patients in the omega-3 group reported a significant improvement in symptoms, compared to 33% of the placebo group.Ī separate meta-analysis of 790 participants in 7 independent studies was analyzed with similar results. A study published in the International Journal of Ophthalmology examined 264 patients with dry eye, to evaluate the benefits of supplementing with omega-3 fatty acids.The study contained two groups 264 people taking 500 mg twice per day (325 mg EPA and 175 mg DHA), while the 254 people in group 2 took a placebo.The results found that increased polyunsaturated fatty acid (PUFA) and monounsaturated fatty acid (MUFA) were associated with lower scores in the depression scale used. This took psychological and dietary data from 453 men and 400 women, then assessed depression using the Zung’s Self-Rating Depression Scale (ZDRS). These were defined by the Center for Epidermiological Studies Depression Scale score.Ī similar study was published in the Journal of the American College of Nutrition. Although this doesn’t mean it’s a cure, symptoms do appear to be relieved by EPA and DHA.One study assessed the diet of 3317 men and women in 1992-1993, which found that people with the highest intakes of EPA and DHA were associated with a lower risk of depressive symptoms. Several studies have found omega-3 fatty acids to be inversely associated with chronic depressive symptoms.One study by Goldberg and Katz in 2007 found that supplementation with EPA and DHA was an effective adjunctive treatment for arthritic pain and joint stiffness.Īfter supplementation with omega-3 PUFAs for 3-4 months, joint pain intensity, minutes of morning stiffness, number of painful joints, and NSAID consumption were all reduced.ģ. Omega-3 fatty acid intake has also been found to improve the symptoms of rheumatoid arthritis. After 1 month of treatment, patients were given a questionnaire to assess whether their pain had improved.Īfter an average of 75 days on fish oil, 60% stated that their joint pain had improved, with 88% saying they would continue to take the fish oil. Nonsteroidal anti-inflammatory drugs (NSAID) are considered an effective therapy for neck and back pain, but have also been associated with side effects such as gastric ulcers and myocardial infarction.This is why one study compared them to Omega-3 EFAs found in fish oil, to find an effective alternative with less side effects.īetween March and June 2004, a 1200 mg daily dose of omega-3 EFAs (EPA and DHA) was given to 250 patients who had been diagnosed with nonsurgical neck or back pain.Curb stiffness and joint pain (Rheumatoid arthritis, Osteoporosis) Patients with hypertriglyceridemia are often prescribed Lovaza™ at a dose of 4g/day, which hasn’t shown any adverse impact on body weight.Ģ.
This is highlighted with the Lovaza™ capsules from GlaxoSmithKline, which contain 465 mg of EPA and 375 mg of DHA.
They also recommend concentrated fish oils, specifically prescription Omacor and Maxepa (170 mg EPA and 115 mg DHA per capsule).It’s important to point out that pharmaceutical control of blood triglycerides is only effective with EPA and DHA, not ALA. Cholesterol charity Heart UK reports that statins can make small reductions in triglyceride levels, in addition to fibrates (Bezafirbdate, Ciprofibrate).
0 kommentar(er)
